USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Antibody-drug Conjugates: Technology Growth Opportunities
Disruptive Technologies and a Conducive Funding Environment are Fostering Growth
21-Dec-2022
Global
Technology Research
DA71-01-00-00-00
HC03622-GL-TR_27305
$4,950.00
Special Price $3,712.50 save 25 %
Antibody-drug conjugates (ADCs) are therapies that target cancer cells with antigen-specific antibodies and highly toxic payloads. ADCs are currently generating interest among drug developers, contract manufacturing companies, regulatory agencies, and other stakeholders. The rise in the number of drug approvals has also sparked interest in further developing this technology, with several companies developing solutions for one or more ADC components. The development of technologies is ongoing and will only increase as applications of ADCs increasingly expand into non-oncologic indications.
This study covers several new technologies for the three ADC components (antibody, linker, and payload) and highlights drugs in clinical trials that display potential. It provides an overview of key technology platforms, patents, analytical techniques, and manufacturing developments, covering the various technological advancements that may see adoption in ADC development. It also provides an overview of the stakeholder ecosystem, identifying notable mergers, acquisitions, and partnerships. A detailed account of the funding landscape has also been provided. The study also analyzes the growth drivers and restraints influencing the market and identifies the key growth opportunities emerging from the changes in this space for stakeholders and market players to leverage.
Why Is It Increasingly Difficult to Grow?The Strategic Imperative 8™: Factors Creating Pressure on Growth
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Antibody-drug Conjugate (ADC) Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Research Methodology
Research Context and Scope
Segmentation
Growth Drivers
Growth Restraints
Introduction to ADCs
Clinical Potential of ADCs
ADCs: FDA Approvals
ADC Industry Trends
Incremental Innovations in ADCs
ADC Challenges and Novel Solutions
ADC Challenges and Novel Solutions (continued)
Characteristics of ADC Linkers
Types of Conventional ADC Linkers
Platforms for ADC Linkers
Platforms for ADC Linkers (continued)
Platforms for ADC Linkers (continued)
Platforms for adc Linkers (continued)
ADC Linker Developments
Platforms to Improve adc Conjugation
Platforms to Improve adc Conjugation (continued)
Platforms to Improve adc Conjugation (continued)
Characteristics of a Suitable Antibody for ADCs
Platforms for ADC Antibodies
Platforms for ADC Antibodies (continued)
Antibody Developments for ADC
Characteristics of a Suitable Cytotoxic Payload for an ADC
Platforms for Cytotoxic Payload for an ADC
Platforms for Cytotoxic Payload for an ADC (continued)
Payload Developments for ADCs
Novel Platforms for ADC Delivery
Impact on CDMOs
ADC: Analysis Technologies, Challenges, and New Developments
ADC: Clinical Pipeline
M&As
Partnerships and Collaborations for ADCs
Partnerships and Collaborations for ADCs (continued)
Partnerships and Collaborations for ADCs (continued)
Technology Licensing Deals for ADC Development
Funding Analysis
Funding Analysis (continued)
Funding Analysis (continued)
Growth Opportunity 1: Non-oncological Indications
Growth Opportunity 1: Non-oncological Indications (continued)
Growth Opportunity 2: Manufacturing and Supply Chain
Growth Opportunity 2: Manufacturing and Supply Chain (continued)
Growth Opportunity 3: Advancements in Linker Chemistry and Antibodies
Growth Opportunity 3: Advancements in Linker Chemistry and Antibodies (continued)
Your Next Steps
Why Frost, Why Now?
Legal Disclaimer
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-car...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Technology Research |
|---|---|
| Author | Lonita lawrence |
| Industries | Healthcare |
| No Index | No |
| Is Prebook | No |
| Keyword 1 | Antibody Drug Conjugate Market |
| Keyword 2 | antibody drug conjugates (ADCs) for cancer therapy |
| Keyword 3 | drug conjugation |
| Podcast | No |
| WIP Number | DA71-01-00-00-00 |